SEC Form 4 · accession 0001209191-18-004999
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Theuer
Officer — President and CEO · Director
Period of report
Jan 22, 2018
Accepted (ET)
Jan 23, 2018 · 7:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2018 | F | 9,290 | $2.95 | D | 76,855 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of restricted stock units.